Get started
Author

Ting-Fang Lu

ORCID: 0009-0000-1338-5614
Observed ORCID: 0009-0000-1338-5614
OpenAlex ID: A5079785025
Disparities in medical recommendations from AI-based chatbots across different countries/regions
2024 · Khanisyah E. Gumilar, Birama R. Indraprasta, et al. · Scientific Reports · 40
Long-term outcome of minimally invasive staging surgery for clinical stage I endometrial cancer: A single institute experience in Taiwan
2023 · Ting-Fang Lu, Chien-Hsing Lu, et al. · Journal of the Chinese Medical Association · 16
A new fertility-preserving treatment modality for life-threatening bleeding caused by acquired uterine arteriovenous malformation (AVM): Combination laparoscopic ligation of uterine arteries and AVM suture
2022 · Ting-Fang Lu, Yu-Hsiang Shih, et al. · Taiwanese Journal of Obstetrics and Gynecology · 11
PDF
Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer
2025 · Shao-Jing Wang, Lou Sun, et al. · BMC Medicine · 7
A retrospective study evaluating the effect of trastuzumab addition to carboplatin/paclitaxel on overall survival in patients with advanced-stage HER2/neu-overexpressing uterine serous carcinoma or carcinosarcoma
2025 · Ting-Fang Lu, Lou Sun, et al. · BMC Medicine · 7
PDF
Case report: Malignant transformation of ovarian endometrioma during long term use of dienogest in a young lady
2024 · Yi-Ting Chang, Ting-Fang Lu, et al. · Frontiers in Oncology · 6
PDF
Lenvatinib Plus Pembrolizumab versus Doxorubicin for Advanced or Recurrent Endometrial Cancer with Short Treatment-Free Intervals Following First-Line Carboplatin Plus Paclitaxel
2024 · Shao-Jing Wang, Hsin-Hua Chen, et al. · Journal of Clinical Medicine · 3
PDF
Efficacy and toxicities of doxorubicin plus ifosfamide in the second-line treatment of uterine leiomyosarcoma
2023 · Szu-Yun Niu, Lou Sun, et al. · Frontiers in Oncology · 3
PDF
Association of hormone therapy with long-term outcomes after chemoradiation for locally advanced cervical cancer
2026 · Ting-Fang Lu, Yu-Hsiang Shih, et al. · American Journal of Obstetrics and Gynecology · 1
Comparative safety of PD-1 and PD-L1 inhibitors in advanced solid tumors: a real-world cohort study with competing risk analysis
2026 · Yu-Hsiang Shih, Shao-Jing Wang, et al. · Cancer Immunology Immunotherapy · 1
PDF
Long-term risk of psychiatric disorders in women with endometriosis: A retrospective cohort study
2025 · Yu-Hsiang Shih, Shao-Jing Wang, et al. · Comprehensive Psychiatry · 1
Treatment-Free Interval as a Prognostic Factor for Survival Outcomes in Patients with Advanced or Recurrent Endometrial Cancer Treated with Pembrolizumab Plus Lenvatinib: A Multi-Institutional Real-World Cohort Study
2026 · Chih-Wen Su, Shao-Jing Wang, et al. · Cancers
Interpreting long-term hormone therapy associations after cervical cancer chemoradiotherapy (reply to letter to the editor)
2026 · Ting-Fang Lu, Yu-Hsiang Shih, et al. · American Journal of Obstetrics and Gynecology
Long-term systemic outcomes of postmenopausal hormone replacement therapy by age at menopause: a real-world cohort study
2026 · Ting-Fang Lu, Chien-Hsing Lu, et al. · Human Reproduction Open
EV250/#838 Comparison of bevacizumab maintenance only with standard bevacizumab throughout treatment in patiens with newly diagnosed advanced ovarian cancer
2024 · Chun Ting Fan, Shao-Jing Wang, et al. · International Journal of Gynecological Cancer
PDF
EV164/#394 Lenvatinib, pembrolizumab versus carboplatin, paclitaxel in pretreated, advanced endometrial cancer
2024 · Shao-Jing Wang, Sun Lou, et al. · International Journal of Gynecological Cancer
PDF
PR017/#164 Adding trastuzumab to carboplatin and paclitaxel improves overall survival in advanced-stage HER2/NEU overexpressing uterine serous carcinoma or carcinosarcoma
2024 · Ting-Fang Lu, Sun Lou, et al. · International Journal of Gynecological Cancer
PDF
Maintenance Chemotherapy in Patients with Platinum-Sensitive Relapsed Epithelial Ovarian Cancer after Second-Line Chemotherapy
2024 · Yen-Fu Chen, Shih-Tien Hsu, et al. · Journal of Clinical Medicine
PDF
Works count: 18
Citation count: 96
H-index: 6
I10-index: 3
Year
Topic
Type